Jason Scharf

The SDSU San Diego Angel Conference (SDAC) is open to any member of the community interested in learning more about starting a company and investing in a new business. The conference is the culmination of many months of due diligence, review, evaluation, and selection by the investors. The entrepreneurial candidates are narrowed down and on the day of the conference, the conference finalists have the opportunity to make their best pitch for why their company deserves the investment.

The SDSU San Diego Angel Conference (SDAC) is open to any member of the community interested in learning more about starting a company and investing in a new business. The conference is the culmination of many months of due diligence, review, evaluation, and selection by the investors. The entrepreneurial candidates are narrowed down and on the day of the conference, the conference finalists have the opportunity to make their best pitch for why their company deserves the investment.

At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. Illumina’s innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.

BD is one of the worlds largest pure-play medical technology companies with a Purpose of advancing the world of health™ by driving innovation across medical essentials, connected care, biopharma systems and interventional. The company supports those on the frontlines of healthcare by developing transformative technologies, services and solutions that optimize clinical operations and improve care for patients. Operating across the globe, with more than 60,000 employees, BD delivers billions of products annually that have a positive impact on global healthcare. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase clinical efficiency, improve safety and expand access to healthcare. For more information on BD, please visit bd.com. See community guidelines here: https://tinyurl.com/yunjmzkx.